Sarcopenia Associated with Cognitive Frailty in Adults Diagnosed with Diabetes: Evidence from Primary Healthcare Centers
DOI:
https://doi.org/10.59784/glosains.v7i3.757Keywords:
Cognitive Frailty, Diabetes, SarcopeniaAbstract
Background: Recent clinical investigations have drawn attention to cognitive frailty as a composite syndrome that occurs with increasing frequency in populations affected by chronic metabolic disorders, most notably type 2 diabetes mellitus. Despite this recognition, empirical data characterizing its prevalence and predisposing determinants among younger, community-dwelling adults with diabetes remain insufficient.
Objective: The aim of this investigation was to determine whether sarcopenia independently contributes to the occurrence of cognitive frailty in adults with diabetes managed within the primary care system.
Methods: Adopting a cross-sectional design, the study recruited 281 adults living with diabetes from two community-based health facilities. The Mini-Mental State Examination (MMSE) served as the primary cognitive assessment tool, and the SARC-F questionnaire—a validated self-report screening instrument rather than a direct physiological measure of muscle mass or handgrip strength—was used to assess sarcopenia risk. Chi-square analysis tested bivariate associations, and adjusted prevalence ratios (PRs) were computed using modified Poisson regression with robust variance, an approach suited for cross-sectional data in which outcomes are not rare.
Results: The overall prevalence of cognitive frailty in the study cohort was 3.2%. In multivariate models, sarcopenia was associated with a significantly higher likelihood of cognitive frailty (adjusted PR = 6.84; 95% CI: 1.55–30.19).
Conclusion: Sarcopenia is a clinically meaningful, independent risk factor for cognitive frailty in community-dwelling adults with diabetes. Integrating parallel assessments of sarcopenia and cognitive function into routine primary care diabetes management may improve early detection and help reduce downstream adverse health outcomes.
References
Barros, A. J., & Hirakata, V. N. (2003). Alternatives for logistic regression in cross-sectional studies: An empirical comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology, 3(1), 21. https://doi.org/10.1186/1471-2288-3-21
Bian, J., Chen, Z., Gao, Y., Lau, F. Y., Fong, D. Y. T., Choi, E. P. H., & Chau, P. H. (2026). Prevalence of cognitive frailty, reversible and potentially reversible cognitive frailty among older adults without dementia: a systematic review and meta-analysis. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 81(1), gbaf228.
Bu, F., Deng, X., Zhan, N., Cheng, H., Wang, Z., Tang, L., Zhao, Y., & Lyu, Q. (2023). Development and validation of a risk prediction model for frailty in patients with diabetes. BMC Geriatrics, 23(1), 172.
Cigolle, C. T., Lee, P. G., Langa, K. M., Lee, Y.-Y., Tian, Z., & Blaum, C. S. (2011). Geriatric conditions develop in middle-aged adults with diabetes. Journal of General Internal Medicine, 26(3), 272–279.
Corral-Pérez, J., Casals, C., Ávila-Cabeza-de-Vaca, L., González-Mariscal, A., Martínez-Zaragoza, I., Villa-Estrada, F., Reina-Campos, R., & Vázquez-Sánchez, M. Á. (2023). Health factors associated with cognitive frailty in older adults living in the community. Frontiers in Aging Neuroscience, 15, 1232460.
Dong, X., Yu, Y., Li, J., Chai, X., Shan, W., Yan, H., & Lu, Y. (2024). A study of the correlation between sarcopenia and cognitive impairment in older individuals over 60 years: cross-sectional and longitudinal validation. Frontiers in Aging Neuroscience, 16, 1489185.
Elmaleh, D. mostafa, & Mohamed, D. M. A. (2025). Sarcopenia and frailty as predictor of outcome in critically ill elderly patients with multiple comorbidities. The Egyptian Journal of Internal Medicine, 37(1), 3. https://doi.org/10.1186/s43162-025-00259-1
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., & Burke, G. (2001). Frailty in older adults: evidence for a phenotype. The Journals of Gerontology Series a: Biological Sciences and Medical Sciences, 56(3), M146–M157. https://doi.org/10.1093/gerona/56.3.m146
Gaspar, P. M., Campos-Magdaleno, M., Pereiro, A. X., Facal, D., & Juncos-Rabadán, O. (2022). Cognitive reserve and mental health in cognitive frailty phenotypes: Insights from a study with a Portuguese sample. Frontiers in Psychology, 13, 968343. https://doi.org/10.3389/fpsyg.2022.968343
Grobbee, D. E., & Hoes, A. W. (2014). Clinical epidemiology: Principles, methods, and applications for clinical research. Jones & Bartlett Publishers.
Hanna, R. M., Ghobry, L., Wassef, O., Rhee, C. M., & Kalantar-Zadeh, K. (2020). Renal replacement therapy preferences survey: Is allo-hemodialysis an acceptable option for patient caregivers and health care professionals? Blood Purification, 49(1–2), 202–211. https://doi.org/10.1159/000504326
Hardi, N., Kristian, K., William, F., Theresia, F., Angelica, P., Kuistono, J. A., Irawan, M. A., & Handayani, Y. S. (2025). Cognitive frailty in urban community-dwelling older adults: Associated physical and psychological risk factors. Journal of Family and Community Medicine, 32(4), 316–323. https://doi.org/10.4103/jfcm.jfcm_XXX
Karp, I. (2014). Re: Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology, 179(8), 1034–1035. https://doi.org/10.1093/aje/kwu038
Kelaiditi, E., et al. (2013). Cognitive frailty: Rationale and definition from an (IANA/IAGG) international consensus group. The Journal of Nutrition, Health and Aging, 17(9), 726–734. https://doi.org/10.1007/s12603-013-0367-2
Liccini, A. P., & Malmstrom, T. K. (2016). Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. Journal of the American Medical Directors Association, 17(9), 846–851. https://doi.org/10.1016/j.jamda.2016.04.007
Liu, H., Fan, Y., Liang, J., et al. (2024). A causal relationship between sarcopenia and cognitive impairment: A Mendelian randomization study. PLoS One, 19(9), e0309124. https://doi.org/10.1371/journal.pone.0309124
Lu, C., Liu, W., Cang, X., et al. (2024). The bidirectional associations between sarcopenia-related traits and cognitive performance. Scientific Reports, 14, 7591. https://doi.org/10.1038/s41598-024-57591-2
Mei, F., Gao, Q., Chen, F., et al. (2021). Frailty as a predictor of negative health outcomes in chronic kidney disease: A systematic review and meta-analysis. Journal of the American Medical Directors Association, 22(3), 535–543. https://doi.org/10.1016/j.jamda.2020.08.029
Pellegrino, R., et al. (2024). Beyond inflammaging: The impact of immune system aging on age-related muscle decline. The Journals of Gerontology: Series A, 79(2), glad238. https://doi.org/10.1093/gerona/glad238
Pöyhönen, J., et al. (2026). Impact of multidomain lifestyle intervention on cognitive frailty: FINGER trial. The Journals of Gerontology: Series A, 81(2), glaf275. https://doi.org/10.1093/gerona/glaf275
Ruan, Q., Yu, Z., Chen, M., et al. (2015). Cognitive frailty: A novel target for prevention of elderly dependency. Ageing Research Reviews, 20, 1–10. https://doi.org/10.1016/j.arr.2014.12.004
Salaffi, F., et al. (2023). Inflammaging and frailty in immune-mediated rheumatic diseases. Clinical Reviews in Allergy & Immunology, 64(2), 206–221. https://doi.org/10.1007/s12016-022-08914-5
Santoso, V., & Rensa, R. (2022). Determinant factors of cognitive frailty in elderly patients. Jurnal Penyakit Dalam Indonesia, 9(4), 21.
Solerte, S. B. (2025). Shared pathways linking metabolic syndrome, cognitive impairment, and sarcopenia. Metabolites, 15(3), 159. https://doi.org/10.3390/metabo15030159
Tamura, Y., et al. (2020). Nutrition management in older adults with diabetes. Nutrients, 12(11), 3367. https://doi.org/10.3390/nu12113367
Vermeiren, S., et al. (2016). Frailty and prediction of negative health outcomes: A meta-analysis. Journal of the American Medical Directors Association, 17(12), 1163.e1–1163.e17. https://doi.org/10.1016/j.jamda.2016.09.006
Wu, Y., et al. (2022). Frailty and microvascular complications in type 2 diabetes. BMC Medicine, 20, 473. https://doi.org/10.1186/s12916-022-02650-1
Xenos, D., et al. (2025). Muscle-brain axis in type 2 diabetes. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102955
Zhang, F., et al. (2023). Frailty and survival in chronic kidney disease. BMC Nephrology, 24, 258. https://doi.org/10.1186/s12882-023-03258-2
Zou, G. (2004). Modified Poisson regression approach. American Journal of Epidemiology, 159(7), 702–706. https://doi.org/10.1093/aje/kwh090
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Laurentius Johan Ardian, Fitria Kusuma Wardhani, Bisarda Kanira, Aura Cinta Jihada, Tia Maya Affrita
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
